| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.22874 |
| P698 | PubMed publication ID | 17546601 |
| P50 | author | Ernst Lengyel | Q39184682 |
| P2093 | author name string | Thomas Krausz | |
| Hilary A Kenny | |||
| Seiko D Yamada | |||
| P2860 | cites work | Reactivity of a monoclonal antibody with human ovarian carcinoma | Q24600879 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1463-1472 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum | |
| P478 | volume | 121 |
| Q52593636 | A 3D Microfluidic Model to Recapitulate Cancer Cell Migration and Invasion. |
| Q87678165 | A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth |
| Q30658829 | A Novel Intravital Imaging Window for Longitudinal Microscopy of the Mouse Ovary |
| Q35817502 | A method to investigate the anti-metabolic activity of anti-cancer agents on ovarian cancer cells cultured in a 96-well high throughput format |
| Q33516890 | A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion |
| Q37722589 | A simplified culture system to examine soluble factor interactions between mammalian cells |
| Q30449030 | A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform |
| Q39185534 | A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro |
| Q89961778 | Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer |
| Q35264283 | Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer |
| Q48109847 | Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis |
| Q36334681 | Advantages of the avian model for human ovarian cancer |
| Q88608129 | Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells |
| Q90647900 | An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment |
| Q64287972 | An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments |
| Q34919480 | An immunocompetent, orthotopic mouse model of epithelial ovarian cancer utilizing tissue engineered tumor cell sheets |
| Q51173657 | An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis. |
| Q97587435 | Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer |
| Q33667156 | Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival |
| Q33792661 | CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells |
| Q99557822 | Calcified peritoneal metastasis due to advanced ovarian cancer: Incidental finding in bone scan and single-photon emission computed tomography-computed tomography |
| Q38184909 | Cancer Systems Biology: a peek into the future of patient care? |
| Q38249099 | Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies |
| Q34887528 | Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer |
| Q38563910 | Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics. |
| Q36844475 | Cancer-associated stromal fibroblasts promote pancreatic tumor progression |
| Q26851836 | Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis |
| Q36122605 | Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis |
| Q33357902 | Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration |
| Q35070149 | Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer development |
| Q37676502 | Culture models to define key mediators of cancer matrix remodeling |
| Q64969004 | Current Status of Patient-Derived Ovarian Cancer Models. |
| Q41575096 | Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion. |
| Q33768443 | Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion |
| Q37260078 | EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma |
| Q37003883 | Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells |
| Q36844539 | Engineering a High-Throughput 3-D In Vitro Glioblastoma Model. |
| Q37708938 | Epithelial ovarian cancer experimental models. |
| Q36208184 | Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer |
| Q58609457 | Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells |
| Q37595267 | Fibroblasts in three dimensional matrices: cell migration and matrix remodeling |
| Q30446755 | Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules |
| Q35203637 | Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. |
| Q51439316 | Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms. |
| Q33927161 | HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin |
| Q36290268 | HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. |
| Q64111448 | High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints |
| Q94465892 | Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors |
| Q36304413 | In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis |
| Q83189336 | In vitro metastatic colonization of human ovarian cancer cells to the omentum |
| Q47557286 | Inferring Molecular Processes Heterogeneity from Transcriptional Data |
| Q91854653 | Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis |
| Q37085845 | Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells |
| Q92826166 | Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells |
| Q37151287 | Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target |
| Q33735265 | MMP-2 functions as an early response protein in ovarian cancer metastasis |
| Q34292996 | Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties |
| Q30579225 | Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance |
| Q34311697 | Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. |
| Q38757603 | Metabolomics: A Primer |
| Q36938409 | MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer |
| Q36086967 | Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis. |
| Q37062819 | Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models |
| Q37119791 | Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms |
| Q33641924 | Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems |
| Q36659620 | Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity |
| Q27333756 | Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. |
| Q90644478 | Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum |
| Q58792683 | Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment |
| Q36837236 | Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis |
| Q37331321 | Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination |
| Q34086819 | Ovarian cancer development and metastasis |
| Q37707040 | P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions |
| Q30446949 | Prediction and control of number of cells in microdroplets by stochastic modeling. |
| Q26773613 | Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics |
| Q27315878 | Protein kinase A activity and anchoring are required for ovarian cancer cell migration and invasion |
| Q34305017 | Quantification of breast cancer cell invasiveness using a three-dimensional (3D) model |
| Q90339423 | Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis |
| Q35592860 | Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. |
| Q26823555 | Role of mesenchymal cells in the natural history of ovarian cancer: a review |
| Q36131297 | SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells |
| Q50479880 | Screening out irrelevant cell-based models of disease. |
| Q38804110 | Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures. |
| Q33581564 | Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms |
| Q64268634 | Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells |
| Q36641872 | Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy? |
| Q34676773 | Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer |
| Q34106013 | Systems microscopy approaches to understand cancer cell migration and metastasis. |
| Q34777224 | Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis |
| Q26783022 | The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis |
| Q33624201 | The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial-stromal interactions |
| Q38824065 | The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer |
| Q35354834 | The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer. |
| Q35931850 | The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer |
| Q36494563 | The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. |
| Q48278671 | The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. |
| Q50914181 | The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation. |
| Q39084731 | The use of porous scaffold as a tumor model |
| Q64062159 | Therapeutic Targeting of Collective Invasion in Ovarian Cancer |
| Q33409977 | Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. |
| Q35591610 | Three-dimensional modeling of ovarian cancer. |
| Q35066327 | Tumor microenvironment-associated modifications of alternative splicing. |
| Q37451733 | Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy |
| Q47614366 | Visualizing the network of Bonghan ducts in the omentum and peritoneum by using Trypan blue |
| Q64921196 | With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment. |
| Q28071987 | miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition |
| Q37413723 | {beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer. |
Search more.